Quick Answer
ANAVEX LIFE SCIENCES CORP. reported Stockholders Equity of $94.87 million for fiscal year 2025.
ANAVEX LIFE SCIENCES CORP. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $94.87M | -21.1% |
| 2024 | $120.26M | -15.2% |
| 2023 | $141.85M | -0.4% |
| 2022 | $142.49M | -5.5% |
| 2021 | $150.82M | +453.7% |
| 2020 | $27.24M | +34.2% |
| 2019 | $20.29M | -9.1% |
| 2018 | $22.32M | -13.8% |
| 2017 | $25.88M | +310.3% |
| 2016 | $6.31M | -50.8% |
| 2015 | $12.81M | +6549.7% |
| 2014 | $192.6K | +107.8% |
| 2013 | -$2.46M | +14.3% |
| 2012 | -$2.88M | -151.7% |
| 2011 | -$1.14M | +61.4% |
| 2010 | -$2.96M | +23.3% |
| 2009 | -$3.86M | -68.3% |
| 2008 | -$2.29M | -395.6% |
| 2007 | -$462.5K | -2881.8% |
| 2006 | -$15.5K | +40.4% |
| 2005 | -$26.0K | -201.6% |
| 2004 | $25.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $126.62M | +14.2% | +33.5% |
| September 30, 2025 | $94.87M | -21.1% | +4.3% |
| June 30, 2025 | $90.96M | -29.9% | -8.8% |
| March 31, 2025 | $99.76M | -26.1% | -10.1% |
| December 31, 2024 | $110.92M | -18.2% | -7.8% |
| September 30, 2024 | $120.26M | -15.2% | -7.3% |
| June 30, 2024 | $129.78M | -11.6% | -3.8% |
| March 31, 2024 | $134.96M | -7.0% | -0.5% |
- ANAVEX LIFE SCIENCES CORP. showed a decrease of -21.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2004–2025 period, ANAVEX LIFE SCIENCES CORP.’s stockholders equity has grown by 370409.7% (from $25.6 thousand to $94.87 million).
- The most recent figure is from ANAVEX LIFE SCIENCES CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: